Influence
July 14, 2025

Risk for metachronous advanced neoplasia in patients with a modified definition of advanced adenoma: data from the New Hampshire colonoscopy registry

Thomas Imperiale

Published in the Clinical Gastroenterology and Hepatology. Here is a link to the article.

Regenstrief Institute authors: Thomas Imperiale, M.D.

A new analysis using data from the New Hampshire Colonoscopy Registry examined the risk of metachronous advanced neoplasia (AN) and colorectal cancer (CRC) in individuals with different subtypes of advanced adenomas (AA). The study focused on comparing patients with 10–19 mm tubular adenomas (TA) to those with modified AA characteristics—high-grade dysplasia (HGD), villous histology, or TA >20 mm.

Among 35,941 adults who underwent follow-up colonoscopy ≥12 months after index screening, five groups were analyzed. Groups 4 (TAs 10–19 mm) and 5 (modified AA) demonstrated higher adjusted risk for metachronous AN compared to low-risk Groups 1–3 (Rate Ratios: 3.67 and 4.69, respectively), with overlapping confidence intervals.

However, when the outcome was restricted to modified AA, Group 5 had a significantly higher risk than Group 4 (RR=1.52; 95% CI, 1.04–2.22). Hazard ratios for CRC were also higher in Groups 4 and 5 (HR=2.44 and 3.52, respectively) compared to the low-risk reference groups, though their confidence intervals overlapped.

These findings indicate that while both larger TAs and modified AA subtypes are associated with increased AN and CRC risk, individuals with HGD, villous features, or larger adenomas may warrant particular attention. The results suggest a need for more precise risk stratification in surveillance guidelines. Further studies are recommended to refine subgroup risks within the 10–19 mm TA population.

Authors: 

Joseph C Anderson1, Todd A Mackenzie2, Lynn F Butterly3, Thomas F Imperiale4

Affiliations: 

1Geisel School of Medicine at Dartmouth, Hanover, NH; White River Junction VAMC, White River Junction VT; NH Colonoscopy Registry, Lebanon, NH. Electronic address: Joseph.Anderson@Dartmouth.edu.

2Geisel School of Medicine at Dartmouth, Hanover, NH.

3Geisel School of Medicine at Dartmouth, Hanover, NH; Department of Gastroenterology and Hepatology, DHMC, Lebanon, NH; NH Colonoscopy Registry, Lebanon, NH.

4Indiana University School of Medicine, Dept of Med., Div. of Gastro/Hep, Indianapolis, IN; Richard L. Roudebush VA Medical Center; Regenstrief Institute, Inc.

Partners

Related News

Shaun Grannis, M.D., M.S.

Effectiveness of 2023–2024 COVID-19 vaccines in children in the U.S.

Published in Pediatrics. Here is a link to the article. Regenstrief Institute author: Shaun Grannis, M.D., M.S., Brian Dixon,

Chris Harle, PhD

Supporting electronic health record data usage in research for teams with varying data science and clinical knowledge: a food service analogy approach

Published in the Journal of the American Medical Informatics Association: JAMIA. Here is a link to the article. Regenstrief

Predictive model, comprehensive data identify risk factors for amputation and death among patients with chronic wounds

Predictive model, comprehensive data identify risk factors for amputation and death among patients with chronic wounds

Findings from Regenstrief Institute’s Chronic Wound Registry may help clinicians and patients make informed decisions and improve outcomes  Chronic wounds affect

Brian Dixon, PhD, MPA (left) and Kathleen Unroe, M.D., MHA (right)

Regenstrief researchers give national presentations on public health informatics and aging

Two Regenstrief Institute research scientists were invited to present their work at nationally recognized grand rounds events, highlighting the